ENVALITH
メック株式会社 logo

MEC COMPANY LTD.

4971・Prime Market・Chemicals

Official website
メック株式会社 logo
MEC COMPANY LTD.4971

Business

MEC Company Ltd. is a research and development-oriented company founded in 1969, primarily engaged in the development, manufacturing, and sale of chemicals for electronic substrates and electronic components. Its flagship product is the Adhesion Promoters (CZ Series), an ultra-roughening treatment agent for semiconductor package substrates, adopted by semiconductor package substrate manufacturers worldwide. The company has its core development and manufacturing base in Japan (Amagasaki), and operates six consolidated subsidiaries in Taiwan, China (Zhuhai/Suzhou), Europe (Belgium), Thailand, and India. Its main customers are electronic substrate and electronic component manufacturers worldwide, and it supplies products for a wide range of applications, from advanced semiconductor package substrates for generative AI-related data centers to general-purpose smartphones and PCs. Chemical sales account for 96.5% (¥20,211 million) of consolidated net sales, complemented by machinery and materials sales.

Business Model

With copper-resin interface treatment technology (roughening and adhesion enhancement) as its core technology, the company manufactures and sells high-quality chemicals at manufacturing sites around the world. It invests approximately 10% of net sales in R&D expenses upfront, continuously developing products that meet customers' needs for improved yield and enhanced functionality, thereby securing high customer retention. The company maintains a high-profitability structure with a gross profit margin of 62.0% and an operating margin of 27.4% for FY2025 (ending December 2025), and practices debt-free management, funding capital expenditures in principle with its own funds.

Company Strengths

The ultra-roughening adhesion promoter "CZ Series" has been adopted by semiconductor package substrate manufacturers worldwide, and is used across a wide range of applications from generative AI-related advanced substrates to general-purpose PCs and smartphones. In FY2025 (ending December 2025), chemical sales reached a record high of ¥20,211 million (up 15.6% year on year), demonstrating the high degree of market penetration of the product.

In FY2025 (ending December 2025), the gross margin was 62.0% (up 1.1 points year on year) and the operating margin was 27.4% (up 2.4 points year on year). The segment margin for the Japan segment reached 31.8%. The company also maintains strong financial soundness, with a debt-free management structure (debt redemption period of 0.0 years) and an equity ratio of 83.7%.

In FY2025 (ending December 2025), R&D expenses totaled ¥1,379 million (approximately 6.6% of sales). About 30% of the 292 employees are assigned to R&D operations, with development functions concentrated at the Japan head office. The company has established a system with five groups—existing product improvement, new field development, wiring pattern formation, metal-resin bonding technology, and machinery development—enabling it to respond quickly to market needs.

ENVALITH's Perspective

In Q1 FY2026 (ending December 2026), sales came to ¥6,128 million (up 38.5% year-on-year), operating profit was ¥2,079 million (up 90.2%), and quarterly net income attributable to owners of the parent was ¥1,528 million (up 220.8%), with sharp increases across all metrics. It should be noted that the large increase in net income partly reflects a rebound from a temporary downward factor in the same period of the previous year, namely an increase in corporate taxes associated with higher dividend income from overseas subsidiaries. In light of the strong Q1 results, the full-year earnings forecast was revised upward to sales of ¥24,500 million (up 17.0% year-on-year) and operating profit of ¥7,600 million (up 32.2%).

The main driver of earnings expansion is growing demand for advanced semiconductor package substrates for generative AI-related data centers, with favorable market tailwinds representing a significant external factor. On the other hand, uncertainty in US trade policy (tariff risk) could affect customers' capital expenditure plans. In addition, the high degree of dependence on the electronic substrate and semiconductor package substrate industry carries the risk of earnings deterioration during industry downcycles. The Europe segment was the only region to post a decline in revenue, down 5.2% year-on-year, and close attention should be paid to the recovery trend following the drop-off in temporary materials demand.

Construction in progress for the launch of the Kitakyushu Plant (tentative name) has expanded to ¥2,956 million (up ¥905 million from the previous fiscal year-end), confirming a proactive investment stance toward future capacity expansion. Meanwhile, the annual dividend forecast for FY2026 (ending December 2026) has been revised to ¥110 (an increase of ¥14 from ¥96 in the previous fiscal year), strengthening shareholder returns as well. Backed by a solid financial base with an equity ratio of 83.3%, the company's financial capacity to pursue both growth investment and shareholder returns simultaneously is commendable. However, the impact of expanded capital expenditure on future profit margins through increased depreciation expenses warrants continued monitoring.

Growth Strategy

Toward realizing the 2030 Vision, the company aims to achieve net sales of ¥25,000 million and an operating margin of 26–30% under the Phase 2 mid-term management plan

Responding to expanding demand for advanced semiconductor package substrates for generative AI-related data centers and for high-performance smartphones, primarily through the CZ Series. In Q1 of FY2026 (ending December 2026), chemical sales reached a record quarterly high of ¥5,997 million, confirming the effectiveness of the strategy.

Construction of the Kitakyushu Plant is underway to meet growing demand. Construction in progress (as an asset account) expanded to ¥2,956 million as of the end of March 2026 (up ¥905 million from the end of the previous fiscal year), reflecting accelerating investment ahead of the plant's operation. Once operational, the plant will reduce supply constraint risk by expanding domestic production capacity.

Capturing the progress of electronic substrate manufacturers' capital investment and plant start-ups in Southeast Asia, the Thailand base achieved rapid growth of 88.8% year-on-year for products related to satellite communications and semiconductor package substrates. Technology deployment activities targeting new markets are also being pursued in parallel, aiming to diversify the global supply network.

The annual dividend forecast for FY2026 (ending December 2026) was revised to ¥110 (¥55 at the end of Q2 and ¥55 at year-end), an increase of ¥14 from the previous fiscal year's actual dividend of ¥96. This clearly demonstrates the policy of strengthening shareholder returns against the backdrop of strong business performance. The dividend payout ratio is expected to be approximately 36% against the forecasted earnings per share of ¥303.93.

Last updated: July 17, 2026